Singapore, Oct. 19 -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the preclinical evaluation and characterisation of therapeutic candidates for various fibrotic diseases, including cancer-associated fibrosis.

The partnership will bring together A*STAR's scientific expertise and therapeutic development capabilities with HistoIndex's proprietary imaging technology and AI-powered fully quantitative tissue analysis.

By providing objective, sensitive and accurate measures of fibrosis and treatment response, HistoIndex's platform will support ...